8BR7
Discovery of IRAK4 Inhibitors BAY1834845 and BAY1830839
This is a non-PDB format compatible entry.
Entity
Entity ID | Chain ID | Description | Type | Chain length | Formula weight | Number of molecules | DB Name (Accession) | Biological source | Descriptive keywords |
1 | AAA, BBB | Interleukin-1 receptor-associated kinase 4 | polymer | 298 | 33286.6 | 2 | UniProt (Q9NWZ3) Pfam (PF07714) In PDB | Homo sapiens (human) | IRAK-4,Renal carcinoma antigen NY-REN-64 |
2 | AAA, BBB | 3-nitro-~{N}-[2-[2-oxidanylidene-2-[4-(phenylcarbonyl)piperazin-1-yl]ethyl]indazol-5-yl]benzamide | non-polymer | 512.5 | 2 | Chemie (R6R) | |||
3 | water | water | 18.0 | 41 | Chemie (HOH) |
Sequence modifications
AAA, BBB: 165 - 460 (UniProt: Q9NWZ3)
PDB | External Database | Details |
---|---|---|
Gly 163 | - | expression tag |
Ser 164 | - | expression tag |
Ala 400 | Lys 400 | engineered mutation |
Ala 401 | Glu 401 | engineered mutation |
Ala 402 | Glu 402 | engineered mutation |
Sequence viewer
Contents of the asymmetric unit
Polymers | Number of chains | 2 |
Total formula weight | 66573.2 | |
Non-Polymers* | Number of molecules | 2 |
Total formula weight | 1025.0 | |
All* | Total formula weight | 67598.2 |